Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Raj Kamal Bahl"'
Autor:
Neena Valecha, Vimal Kant Goyal, Deo Nidhi Mishra, Rashmi Ranjan Das, Neeraj Jauhri, Alok Chandra Bhardwaj, Omesh Khurana, Reena Choudhury, Madhukar Pandey, Bantwal Shantharam Baliga, Susanta Kumar Ghosh, Bina Srivastava, Santhosh T Soans, Raj Kamal Bahl, Ajay Punj, Arjun Roy, Sanjay K Sharma, Amit Nasa, Rajinder K Jalali, Anupkumar R Anvikar
Publikováno v:
Journal of Vector Borne Diseases, Vol 57, Iss 3, Pp 213-220 (2020)
Background & objectives: In India, the burden of Plasmodium vivax malaria has been projected to be highest in some areas. This study investigated the efficacy and safety of fixed dose combination (FDC) of arterolane maleate (AM) 37.5 mg and piperaqui
Externí odkaz:
https://doaj.org/article/896bfb1bbbf64977a887505c0531de99
Autor:
Deo Nidhi Mishra, Alok Chandra Bhardwaj, Rashmi Ranjan Das, Anupkumar R. Anvikar, Reena Choudhury, Neena Valecha, Madhukar Pandey, Neeraj Jauhri, Amit Nasa, Bina Srivastava, Raj Kamal Bahl, Vimal Kant Goyal, Ajay Punj, Santhosh T Soans, Rajinder K. Jalali, Sanjay K Sharma, Omesh Khurana, Bantwal Shantharam Baliga, Arjun Roy, Susanta K. Ghosh
Publikováno v:
Journal of Vector Borne Diseases, Vol 57, Iss 3, Pp 213-220 (2020)
Background & objectives: In India, the burden of Plasmodium vivax malaria has been projected to be highest in some areas. This study investigated the efficacy and safety of fixed dose combination (FDC) of arterolane maleate (AM) 37.5 mg and piperaqui
Autor:
Neena, Valecha, Vimal Kant, Goyal, Deo Nidhi, Mishra, Rashmi Ranjan, Das, Neeraj, Jauhri, Alok Chandra, Bhardwaj, Omesh, Khurana, Reena, Choudhury, Madhukar, Pandey, Bantwal Shantharam, Baliga, Susanta Kumar, Ghosh, Bina, Srivastava, Santhosh T, Soans, Raj Kamal, Bahl, Ajay, Punj, Arjun, Roy, Sanjay K, Sharma, Amit, Nasa, Rajinder K, Jalali, Anupkumar R, Anvikar
Publikováno v:
Journal of vector borne diseases. 57(3)
In India, the burden of Plasmodium vivax malaria has been projected to be highest in some areas. This study investigated the efficacy and safety of fixed dose combination (FDC) of arterolane maleate (AM) 37.5 mg and piperaquine phosphate 187.5 mg (PQ